Foveal avascular zone vessel density is associated with visual field progression in early-stage glaucoma eyes with central visual field damage.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
25 10 2023
25 10 2023
Historique:
received:
23
06
2023
accepted:
20
10
2023
medline:
27
10
2023
pubmed:
26
10
2023
entrez:
25
10
2023
Statut:
epublish
Résumé
We investigated the relationship between foveal avascular zone (FAZ)-related parameters, assessed by optical coherence tomography angiography (OCT-A), and visual field (VF) progression in early-stage open-angle glaucoma (OAG) eyes with central visual field (CVF) defects. Early-stage glaucoma eyes [VF mean deviation (MD) ≥ - 6 dB] with CVF defects were included. The rates of longitudinal change in FAZ-related parameters and structural parameters were evaluated and compared between VF progressors and non-progressors, using linear mixed effects models. Cox proportional hazards model and linear regression models were used to identify factors associated with VF progression, the VF MD reduction rate and the change rate of mean total deviation in central 12 VF points (MTD
Identifiants
pubmed: 37880406
doi: 10.1038/s41598-023-45541-1
pii: 10.1038/s41598-023-45541-1
pmc: PMC10600159
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
18285Informations de copyright
© 2023. Springer Nature Limited.
Références
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT242-6
pubmed: 27409478
Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):29
pubmed: 34846516
Ophthalmology. 2014 Jan;121(1):93-99
pubmed: 23962652
Arch Ophthalmol. 2011 May;129(5):562-8
pubmed: 21555607
Am J Ophthalmol. 2022 May;237:241-258
pubmed: 34902325
Retina. 2018 Oct;38(10):2067-2072
pubmed: 28902097
Br J Ophthalmol. 2023 Nov 22;107(12):1828-1833
pubmed: 36150750
Br J Ophthalmol. 2023 Feb;107(2):207-214
pubmed: 34426401
Am J Ophthalmol. 2017 Dec;184:63-74
pubmed: 28964806
Ophthalmology. 2009 Jun;116(6):1119-24
pubmed: 19376593
Transl Vis Sci Technol. 2018 Aug 27;7(4):20
pubmed: 30159212
PLoS One. 2017 Sep 21;12(9):e0184948
pubmed: 28934255
Transl Vis Sci Technol. 2019 Sep 11;8(5):2
pubmed: 31555493
J Glaucoma. 2018 Jun;27(6):481-489
pubmed: 29664832
Sci Rep. 2019 Nov 14;9(1):16813
pubmed: 31728047
Biomed Opt Express. 2021 May 07;12(6):3228-3240
pubmed: 34221656
Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5510-6
pubmed: 18708621
Korean J Ophthalmol. 2015 Apr;29(2):102-8
pubmed: 25829826
Ophthalmology. 2018 Apr;125(4):588-596
pubmed: 29224927
Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4143-4153
pubmed: 30105369
Am J Ophthalmol. 2018 Mar;187:92-98
pubmed: 29317211
Ophthalmology. 2020 Aug;127(8):1043-1052
pubmed: 32085875
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1637-1645
pubmed: 28297029
Ophthalmology. 2017 May;124(5):709-719
pubmed: 28196732
Am J Ophthalmol. 2022 Apr;236:154-163
pubmed: 34653358
Am J Ophthalmol. 2022 May;237:193-203
pubmed: 34801510
Invest Ophthalmol Vis Sci. 2021 Mar 1;62(3):39
pubmed: 33783486
Invest Ophthalmol Vis Sci. 2008 May;49(5):1907-15
pubmed: 18436824
Ophthalmology. 2011 Sep;118(9):1782-9
pubmed: 21665283
Ophthalmology. 1999 Nov;106(11):2144-53
pubmed: 10571351
Graefes Arch Clin Exp Ophthalmol. 2016 Jun;254(6):1051-8
pubmed: 26338819
Br J Ophthalmol. 2020 Jun;104(6):822-826
pubmed: 31530565
J Comp Neurol. 1990 Oct 1;300(1):5-25
pubmed: 2229487
Ophthalmology. 2023 May;130(5):462-468
pubmed: 36693593
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT504-10
pubmed: 27454659